Ann M Bode

1990 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles
Ascorbic Acid Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Liver Chemical Compounds
Rats Chemical Compounds
Phosphorylation Medicine & Life Sciences
Dehydroascorbic Acid Medicine & Life Sciences
Glucose-6-Phosphatase Chemical Compounds
Human Herpesvirus 4 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2020

Chemoprevention
beta Catenin
Colonic Neoplasms

AgStar Research Project

Bode, A. M.

AGSTAR FINANCIAL SERVICES ACA

1/25/1612/31/16

Project: Research project

research project
Skin Neoplasms
Colonic Neoplasms
Ornithine Decarboxylase Inhibitors

AgStar Research Project

Bode, A. M.

AGSTAR FINANCIAL SERVICES ACA

1/15/1512/31/15

Project: Research project

research project

Research Output 1990 2019

3,3’-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2

Tian, X., Liu, K. D., Zu, X., Ma, F., Li, Z., Lee, M. H., Chen, H., Li, Y., Zhao, Y., Liu, F., Oi, N., Bode, A. M., Dong, Z. & Kim, D. J., Apr 28 2019, In : Cancer Letters. 448, p. 20-30 11 p.

Research output: Contribution to journalArticle

Heterografts
Colon
Growth
Neoplasms
Colonic Neoplasms

Corrigendum: Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models (Oncology Reports (2018) 40 (1545-1553) DOI: 10.3892/or.2018.6313)

Lubet, R. A., Steele, V. E., Juliana, M. M., Bode, A. M., Moeinpour, F. & Grubbs, C. J., Jan 1 2019, In : Oncology Reports. 41, 1, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Emotions
Breast Neoplasms
2-Propanol
Amines
Publications
1 Citation (Scopus)

EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter

Shi, F., Zhou, M., Shang, L., Du, Q., Li, Y., Xie, L., Liu, X., Tang, M., Luo, X., Fan, J., Zhou, J., Gao, Q., Qiu, S. J., Wu, W., Zhang, X., Bode, A. M. & Cao, Y., Jan 1 2019, In : Theranostics. 9, 9, p. 2424-2438 15 p.

Research output: Contribution to journalArticle

Open Access
Human Herpesvirus 4
Fumarates
Epstein-Barr Virus Infections
Epigenomics
Methylation

Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo

Xie, X., Liu, K., Liu, F., Chen, H., Wang, X., Zu, X., Ma, X., Wang, T., Wu, Q., Zheng, Y., Bode, A. M., Dong, Z. & Kim, D. J., Feb 1 2019, In : Cancer Letters. 442, p. 126-136 11 p.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Growth
MAP Kinase Kinase 3
gossypetin
In Vitro Techniques

PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation

Du, Q., Tan, Z., Shi, F., Tang, M., Xie, L., Zhao, L., Li, Y., Hu, J., Zhou, M., Bode, A. M., Luo, X. & Cao, Y., Jun 1 2019, In : Cancer Science. 110, 6, p. 2050-2062 13 p.

Research output: Contribution to journalArticle

Open Access
Carnitine
Transferases
Fatty Acids
Radiation
Radiotherapy